Relevant research to an ageing population
On average more than 70% of the drugs used in society are used by the elderly. Many of the diseases that are the focus of the research in our programme are also age-related. Cancer, COPD, fibrosis, Parkinsonism and influenza are all diseases that become increasingly problematic in an ageing population. So research on new drugs is by definition highly relevant to the ageing population.
We collaborate with departments such as Oncology, Pulmonology, Surgery, Gastroenterology and Hepatology. Our collaborations are essential and an important aspect of daily research routine:
- they ensure the translational character of the research
- and provide us with real-life feedback on our research efforts
- inspire future research.
- facilitate full drug development up to market introduction
Our combined efforts increase the societal and economic value of our research.